Press release
In-Depth Analysis of the Roxadustat Market: Growth Opportunities, Key Trends, and Forecast 2025-2034
Roxadustat
The growing number of individuals with chronic kidney disease (CKD) is expected to drive the growth of the Roxadustat market. CKD is a long-term condition in which the kidneys progressively lose their ability to function properly, potentially leading to kidney failure if untreated. The rising number of CKD patients globally is attributed to factors such as aging populations, increased rates of diabetes, hypertension, and unhealthy lifestyles. Roxadustat aids in managing CKD by stimulating erythropoietin production, which enhances red blood cell production and helps address anemia commonly associated with CKD, thereby improving kidney function and patients' quality of life. For example, in December 2024, the Australian Institute of Health and Welfare (AIHW), an Australian government agency, reported a modest increase in mortality rates from CKD, rising by 4.2% in 2021 and 6.2% in 2022. Therefore, the rising prevalence of CKD is driving the growth of the Roxadustat market.
Get Your Roxadustat Market Report Here:
https://www.thebusinessresearchcompany.com/report/roxadustat-global-market-report
What Is the projected market size and growth rate for the roxadustat market?
The Roxadustat market has grown significantly, increasing from $6.44 billion in 2024 to $6.92 billion in 2025 at a CAGR of 7.5%. This growth is attributed to regulatory approvals in major markets, strong clinical trial outcomes, an increasing prevalence of chronic kidney disease (CKD), greater awareness of anemia management, and government support for anemia treatments.
The Roxadustat market is anticipated to see steady growth, reaching $9.16 billion by 2029 at a CAGR of 7.3%. Growth will be driven by ongoing research for new therapeutic indications, rising healthcare expenditures, demand for non-injectable anemia treatments, improved reimbursement policies, and an aging population. Key trends include a shift toward oral anemia treatments, increased competition from alternative therapies, expansion of licensing agreements, growing investments in hypoxia-inducible factor research, and a focus on patient-centric treatment approaches.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21280&type=smp
What new trends are reshaping the roxadustat market and its opportunities?
Companies operating in the Roxadustat market are opting for reimbursement under Ireland's high-tech drugs scheme to make their therapies more accessible and affordable, thus accelerating market uptake. The high-tech drugs scheme provides reimbursement for expensive, highly specialized medications often prescribed in hospital settings. For instance, in September 2022, Astellas Pharma announced that its Roxadustat (EVRENZO) had been granted reimbursement under this scheme. Roxadustat is the first oral hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor licensed and reimbursed in Ireland. Clinical results showed that Roxadustat was effective in maintaining target hemoglobin levels in patients with symptomatic anemia of chronic kidney disease (CKD), regardless of dialysis status.
What major market segments define the scope and growth of the roxadustat market?
The roxadustat market covered in this report is segmented -
1) By Type: 20mg, 50mg
2) By Product Formulation: Oral Tablets
3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers
4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions
Subsegments:
1) By 20mg: Oral Tablets, Injectable Formulations
2) By 50mg: Oral Tablets, Injectable Formulations
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21280
Which region dominates the roxadustat market?
North America was the largest region in the Roxadustat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roxadustat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the roxadustat industry growth?
Major companies operating in the roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21280&type=smp
What Is Covered In The Roxadustat Global Market Report?
•Market Size Forecast: Examine the roxadustat market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the roxadustat market for a structured understanding.
•Key Players Overview: Analyze major players in the roxadustat market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the roxadustat market.
•Segment Contributions: Evaluate how different segments drive overall growth in the roxadustat market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the roxadustat market.
•Industry Challenges: Identify potential risks and obstacles affecting the roxadustat market.
•Competitive Landscape: Review strategic developments in the roxadustat market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Analysis of the Roxadustat Market: Growth Opportunities, Key Trends, and Forecast 2025-2034 here
News-ID: 3934612 • Views: …
More Releases from The Business Research Company
Impact Of Rising Infrastructure Investment On The Market Growth Due To Increasin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Hydrophilic Swelling Waterstop Market Through 2025?
In recent times, there has been robust growth in the hydrophilic swelling waterstop market size. It is expected to mature from a value of $0.87 billion in 2024 to $0.94 billion in 2025, illustrating a compound…
Emerging Trends to Drive Hot Melt Waterproofing System Market Growth at 7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hot Melt Waterproofing System Market Size Growth Forecast: What to Expect by 2025?
There has been a substantial expansion in the hot melt waterproofing system market in the last few years. It is projected to rise from $2.34 billion in 2024 to $2.52 billion in 2025, with a compound…
High-Pressure Blasting Service Market: Major Trends Reshaping the Future of the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the High-Pressure Blasting Service Industry Market Size Be by 2025?
The market size for high pressure blasting services has seen substantial growth in the past few years. The market, which is predicted to rise from a value of $3.18 billion in 2024 to $3.40 billion in 2025,…
Impact Of Rising Construction Activities On The Market Growth Due To Increasing …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
High Performance Plasterboard Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the last few years, there has been a robust expansion of the high performance plasterboard market size. It's predicted to increase from $13.32 billion in 2024 to $14.21 billion in 2025, showcasing a…
More Releases for Roxadustat
Roxadustat Market Size Projected To Reach 9.15 Billion By 2034 With A Cagr Of 7. …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Roxadustat Market?
Over the past few years, the Roxadustat market has exhibited robust growth. It is projected to rise from $6.44 billion in 2024 to $6.92 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Factors such as regulatory green signals in…
Roxadustat Market Industry Analysis by Size, Share, Growth, Sourcing Strategy, S …
" As of 2024, the global Roxadustat market is valued at approximately $1.1 billion, driven by increasing demand for innovative therapies to treat anemia, particularly in patients with chronic kidney disease (CKD). The market is projected to grow to around $3.2 billion by 2034, reflecting a robust expansion fueled by an aging population, escalating CKD prevalence, and ongoing clinical research into Roxadustat's efficacy."
Exactitude Consultancy., Ltd. released a research report titled…
Roxadustat Market Industry Analysis by Size, Share, Growth, Sourcing Strategy, S …
" As of 2024, the global Roxadustat market is valued at approximately $1.1 billion, driven by increasing demand for innovative therapies to treat anemia, particularly in patients with chronic kidney disease (CKD). The market is projected to grow to around $3.2 billion by 2034, reflecting a robust expansion fueled by an aging population, escalating CKD prevalence, and ongoing clinical research into Roxadustat's efficacy."
Exactitude Consultancy., Ltd. released a research report titled…
Chemotherapy Induced Anemia Market Forecast 2032: FDA, EMA, PDMA Approvals, Clin …
Chemotherapy Induced Anemia companies are Astellas, FibroGen, AstraZeneca, Aileron Therapeutics, Zydus Cadila, Pfizer Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Amgen Inc., Novartis AG, 3SBio Group, Bristol-Myers Squibb, FibroGen, and others.
(Albany, USA) DelveInsight's "Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chemotherapy Induced Anemia, historical and forecasted epidemiology as well as the Chemotherapy Induced Anemia market trends in the United States, EU5…
Chemotherapy Induced Anemia Pipeline Analysis (2023) Covering Clinical Trials, E …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are actively developing novel therapies in the Chemotherapy Induced Anemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Chemotherapy Induced Anemia Pipeline Insight, 2023" report…
Roxadustat API Market Size, Growth, Trends, Share & Forecast 2023-2029|
Los Angeles, United States,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Roxadustat API market. It sheds light on how the global Roxadustat API market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Roxadustat API…
